Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Signal Transduction
Stem Cells
Product Type
All Products
New Products
Small Molecules
Peptides
Antibodies
Jena Bioscience
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular Disease
Endocrinology
Immunology
Metabolic Disease
Neurological Disease
Pain & Inflammation
Respiratory Disease
Home »
Cellular Processes » Signal Transduction » Protein Translocation, Exocytosis and Endocytosis » Levetiracetam
LevetiracetamCat No. 2839 |
Price and Availability |
|
Alternative Names: Keppra, UCB L059 Chemical Name: (2S)-(2-Oxopyrrolidin-1-yl)butyramide |
|
Biological Activity
Antiepileptic that displays distinctive properties from conventional antiepileptic drugs. Displays potent seizure protection in animal models of chronic epilepsy but lacks activity in acute seizure models. Binds synaptic vesicle protein 2A (SV2A) and inhibits Na+-dependent Cl-/HCO3- exchange.Technical Data
M.Wt:170.21
Formula:C8H14N2O2
Solubility:Soluble to 100 mM in water and to 100 mM in DMSO
Purity: >99 %
Storage:Store at RT
CAS No:[102767-28-2]
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.
Resources
Certificate of Analysis / MSDS
Certificate of Analysis: View current batch
Material Safety Data Sheet: View current batch
References
Lynch et al (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proct.Natl.Acad.Sci. USA 101 9861. Smedt et al (2007) Levetiracetam: the profile of a novel anticonvulsant drug - part I: preclinical data. CNS Drug Rev. 13 43. Ueda et al (2007) Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection. Brain Res. 1151 55.If you know of a useful citation for this product please let us know.
Keywords: Levetiracetam, Anti-epileptic, binds, SV2A, Exocytosis, Endocytosis, Protein, Translocation
Buy Now / Print Quote
Find multiple products by catalog number
New Products in this Area
GANT 58
GLI1 antagonist; inhibits Hh signaling
Eeyarestatin IPotent inhibitor of ER-associated protein degradation and translocation
SANT-2Inhibitor of hedgehog (Hh) signaling; antagonizes smoothened activity
EHT 1864Potent inhibitor of Rac family GTPases
Sign-up for new product e-alerts
New Product Guide
Highlights over 250 new products added in 2009/10. Request a copy or view PDF today.



